The identified variant truncates the protein, abolishes the C-terminal SET domain required for histone methyltransferase activity, and is predicted to trigger nonsense-mediated mRNA decay, resulting in KMT2A haploinsufficiency-the primary pathogenic mechanism of Wiedemann-Steiner syndrome. The gene discussed is KMT2A; the disease is Wiedemann-Steiner syndrome.